Tannin-albumin particles as stable carriers of medicines

Nanomedicine (Lond). 2024 Apr;19(8):689-708. doi: 10.2217/nnm-2023-0275. Epub 2024 Feb 13.

Abstract

Background: The effectiveness of a drug is dependent on its accumulation at the site of therapeutic action, as well as its time in circulation. The aim of the research was the creation of stable albumin/tannin (punicalagin, punicalin) particles, which might serve for the delivery of medicines. Methods: Numerous chromatographic and analytical methods, docking analyses and in vivo testing were applied and used. Results: Stable tannin-albumin/medicine particles with a diameter of ∼100 nm were obtained. The results of in vivo experiments proved that tannin-albumin particles are more stable than albumin particles. Conclusion: Based on the experiments and docking analyses, these stable particles can carry an extended number of medicines, with diverse chemical structures.

Keywords: docking analyses; human serum albumin; nanocarriers; punicalagin; punicalin; stability; therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albumins
  • Antioxidants
  • Drug Carriers
  • Phagocytosis
  • Plant Extracts* / chemistry
  • Tannins*

Substances

  • Tannins
  • Plant Extracts
  • Albumins
  • Antioxidants
  • Drug Carriers